MR. JOEL EDWARD KLEINMAN, M.D., PH.D.
Psychiatric at Jenifer St, Washington, DC
License number
DC MD12090
Category
Neurology
Type
Neurology
License number
DC MD12090
Category
Psychiatric
Type
Psychiatry
Address
Address
3734 Jenifer St NW, Washington, DC 20015
Phone
(202) 363-4846
(202) 363-2025 (Fax)
(202) 363-2025 (Fax)
Professional information
Joel B Kleinman, Washington DC - Lawyer
Address:
Dickstein Shapiro Llp
1825 I St NW, Washington 20006
(202) 420-2221
1825 I St NW, Washington 20006
(202) 420-2221
Licenses:
Dist. of Columbia - Active 1975
Education:
Georgetown University Law CenterDegree JD - Juris Doctor
Specialties:
Antitrust / Trade Law - 34%
Insurance - 33%
Environmental / Natural Resources - 33%
Insurance - 33%
Environmental / Natural Resources - 33%
Partner At Dickstein Shapiro Llp
Position:
partner at Dickstein Shapiro LLP
Location:
Washington D.C. Metro Area
Industry:
Law Practice
Work:
Dickstein Shapiro LLP
-
partner
Dr. Joel E Kleinman, Washington DC - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
3734 Jenifer St NW, Washington 20015
(202) 363-4846 (Phone), (202) 363-2025 (Fax)
(202) 363-4846 (Phone), (202) 363-2025 (Fax)
Certifications:
Psychiatry, 1978
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1973
San Francisco General Hospital
George Wash U
Mass Mh Ctr
Harvard University
U Calif
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1973
San Francisco General Hospital
George Wash U
Mass Mh Ctr
Harvard University
U Calif
Schizophrenia-Related Isoform Of Kcnh2 And Development Of Antipsychotic Drugs
US Patent:
2010010, Apr 29, 2010
Filed:
Mar 21, 2008
Appl. No.:
12/593159
Inventors:
Daniel R. Weinberger - Washington DC, US
Stephen J. Huffaker - Crawfordsville IN, US
Joel E. Kleinman - Washington DC, US
Bai Lu - Bethesda MD, US
Stephen J. Huffaker - Crawfordsville IN, US
Joel E. Kleinman - Washington DC, US
Bai Lu - Bethesda MD, US
Assignee:
THE UNITED STATES OF AMERICA,AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICE - Bethesda MD
International Classification:
A61K 38/00, C07H 21/00, C07K 14/00, C12N 15/74, C12N 5/16, C12P 21/00, C07K 16/00, G01N 33/53, A61P 25/18
US Classification:
514 12, 536 231, 530350, 4353201, 435348, 435 691, 5303871, 435 721, 436 86
Abstract:
The invention is related to a novel primate specific brain isoform of the potassium channel KCNH2 and genetic association with risk for schizophrenia.